FDA Device recall Z-1869-2014
MOSAIQ MOSAIQ is an oncology information system used to manage workflows for treatment planning and delivery
- FDA Device
- Class II
- terminated
- Published 2014-07-02
On 2014-07-02 the FDA classified a Class II recall of MOSAIQ MOSAIQ is an oncology information system used to manage workflows for treatment planning and delivery by Elekta, citing MOSAIQ does not re-calculate the agent volume when the user changes the ordering dose (to other than what was calculated) prior to saving the order.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1869-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-05-29 |
| Published | 2014-07-02 |
| Last updated | 2026-09-13 11:53 UTC |
| Company | Elekta |
| Distribution | US |
Product
MOSAIQ MOSAIQ is an oncology information system used to manage workflows for treatment planning and delivery. It supports information flow among healthcare facility personnel and can be used where ever radiotherapy and/or chemotherapy are prescribed.
Reason
MOSAIQ does not re-calculate the agent volume when the user changes the ordering dose (to other than what was calculated) prior to saving the order.
Identifiers
| code_info | Released builds 2.50.04D5 and higher |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:53 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1869-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.